Morgan Stanley Upgrades ResMed (RMD) to Overweight

July 31, 2015 10:01 AM

Morgan Stanley upgraded ResMed (NYSE: RMD) from Equalweight to Overweight.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.